CTC Bio Overview
- Year Founded
-
1993

- Status
-
Public
- Employees
-
257

- Stock Symbol
-
060590

- Investments
-
2
- Share Price
-
$4.62
- (As of Monday Closing)
CTC Bio General Information
Description
CTC Bio Inc is engaged in the manufacturing and distribution of pharmaceutical products, veterinary medicines, feed additives, feed ingredients, and functional foods.
Contact Information
Website
www.ctcbio.comCorporate Office
- 901, Tower A, Geumgangpenterium IX Tower
- 27, Dongtancheomdansaneop 1-ro
- Hwaseong-si, Gyeonggi-do
- South Korea
Corporate Office
- 901, Tower A, Geumgangpenterium IX Tower
- 27, Dongtancheomdansaneop 1-ro
- Hwaseong-si, Gyeonggi-do
- South Korea
CTC Bio Timeline
CTC Bio Stock Performance
As of 14-Jul-2025, CTC Bio’s stock price is $4.62. Its current market cap is $110M with 23.9M shares.
(As of Monday Closing)
Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
---|---|---|---|---|---|---|
$4.62 | $4.66 | $4.19 - $6.72 | $110M | 23.9M | 30.7K | -$0.13 |
CTC Bio Financials Summary
As of 31-Mar-2025, CTC Bio has a trailing 12-month revenue of $104M.
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
---|---|---|---|---|
EV | 121,674 | 115,617 | 206,031 | 131,644 |
Revenue | 104,171 | 105,836 | 105,456 | 127,856 |
EBITDA | 3,727 | 2,390 | (5,541) | 7,393 |
Net Income | (3,084) | (3,826) | (11,922) | 3,640 |
Total Assets | 101,137 | 104,339 | 128,707 | 147,537 |
Total Debt | 21,996 | 22,315 | 27,384 | 31,640 |
CTC Bio Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
CTC Bio Patents
CTC Bio Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3150011-A1 | Intraoral fast disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation | Pending | 09-Aug-2019 | ||
EP-4011366-A1 | Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation | Pending | 09-Aug-2019 | ||
EP-4011366-A4 | Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation | Pending | 09-Aug-2019 | ||
US-20230073516-A1 | Intraoral fast-disintegrating formulation containing hemp oil extract or hemp powder extract as raw material of formulation | Inactive | 09-Aug-2019 | ||
CA-3089821-A1 | Capsule filling apparatus | Active | 02-Feb-2018 | A61J3/074 |
CTC Bio Signals
CTC Bio Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
CTC Bio Investments & Acquisitions (2)
CTC Bio’s most recent deal was a Corporate Asset Purchase with SK Chemical (Ansan Plant). The deal was made on 01-Sep-2014.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
SK Chemical (Ansan Plant) | 01-Sep-2014 | Corporate Asset Purchase | Buildings and Property | ||
LG Life Sciences (Animal Drug Business) | 01-Apr-2007 | Merger/Acquisition | Pharmaceuticals |
CTC Bio FAQs
-
When was CTC Bio founded?
CTC Bio was founded in 1993.
-
Where is CTC Bio headquartered?
CTC Bio is headquartered in Hwaseong-si, South Korea.
-
What is the size of CTC Bio?
CTC Bio has 257 total employees.
-
What industry is CTC Bio in?
CTC Bio’s primary industry is Biotechnology.
-
Is CTC Bio a private or public company?
CTC Bio is a Public company.
-
What is CTC Bio’s stock symbol?
The ticker symbol for CTC Bio is 060590.
-
What is the current stock price of CTC Bio?
As of 14-Jul-2025 the stock price of CTC Bio is $4.62.
-
What is the current market cap of CTC Bio?
The current market capitalization of CTC Bio is $110M.
-
What is CTC Bio’s current revenue?
The trailing twelve month revenue for CTC Bio is $104M.
-
What is CTC Bio’s annual earnings per share (EPS)?
CTC Bio’s EPS for 12 months was -$0.13.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »